Ciel Medical is solving unmet clinical needs in the ICU.

Our Products

The Sherpa Suction System

VAP Prevention

VAP is an expensive and deadly hospital-acquired infection (HAI) leading to increased intensive care and hospital length of stay, increased mortality risk and increased direct medical costs1. Aspiration is widely recognized as the primary etiology of VAP but current subglottic suction ETTs are expensive and require broad, non-selective upfront use2.

1Infect Control Hosp Epidemiol 2014;35(8):915-936
2Chest 2001;119;228-235

Our Solution

The Sherpa Suction System enables above-the-cuff placement of a suction catheter allowing for removal of pooled secretions3. It is designed to help reduce aspiration and the subsequent risk of VAP cost effectively. Compared to subglottic suction ETTs our suction system may be able to reduce costs by allowing for selective use in only the patients that need it.

3Crit Care Med 2016; Vol 44; Number 12; Abstract 1003

Watch a quick video about the Sherpa Suction System.


The NEMO Gauge

Tube Location

Location of the endotracheal tube in a ventilated patient's airway is critical to ensure appropriate ventilation. Current standard of care is to confirm tube location by a chest x-ray. This can cause ICU workflow inefficiencies, additional patient radiation exposure and add to ICU cost.

Our Solution

Our solution is the NEMO Gauge - a simple, disposable catheter that can be used to measure endotracheal tube position quickly. NEMO can be used in combination with confirming x-rays which may take longer. NEMO can reduce the time to check the tube position4.

4Data on file at Ciel Medical

Watch a quick video about the NEMO Gauge.


Our Team

Kate Garrett, Co-Founder & CEO

Kate is the co-founder and CEO of Ciel Medical. Prior to Ciel Medical Kate worked in strategic marketing at Acclarent, and in R&D at Pathway Medical Technologies. She has been directly involved in the development and commercial launch of six 510(k) products. Kate has a mechanical engineering degree from Olin College and graduated from the Stanford Biodesign Fellowship for medtech innovation.

Dan Azagury, MD, Co-Founder & Board Member

Dan is the co-founder of Ciel Medical and an Assistant Professor of Surgery at Stanford University specializing in bariatric and minimally invasive surgery. Dan is on faculty at multiple medical innovation courses around the globe including Stanford Biodesign, Strausburg IHU BEST and Barcelona d.Health. He completed his medical training at Geneva University Hospital, surgery fellowships at Brigham & Women’s Hospital and the Biodesign Fellowship at Stanford University.

Jay Watkins, Board Member

Jay Watkins is a Managing Director at Curation Capital. Jay is an operating executive with extensive experience founding and funding healthcare companies including executive management roles at DeNovo Ventures, Guidant Corp and Origin MedSystems. He has served as a board member for both private and public medtech companies and has been an active advisor and faculty member for the Kauffman Labs program which is dedicated to educating and training founders. Jay received his MBA from Harvard Business School and his undergraduate degree from Stanford University.

Beverly Huss, Board Member

Beverly Huss is the President and CEO of Qool Therapeutics. Previously, she was President and CEO of Vibrynt, Inc. and a senior executive at Guidant Corp. Beverly serves on the board of Ulthera, Ciel Medical and the University of Illinois Material Science and Engineering steering committee and previously served on the boards of Dade Behring, Inc., Wright Medical Inc., and Artes Medical. She was the recipient of the 2013 University Of Illinois College Of Engineering Alumni Award for distinguished leadership in the medical device industry. Beverly holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois.

Steve Ruoss, MD, Advisor

Steve Ruoss is the Clinical Chief, Division of Pulmonary and Critical Care Medicine at Stanford University School of Medicine. Steve is an entrepreneur and advisor to early stage medical device start-ups.

Alex Tilson, Advisor

Alex Tilson was the founder and CEO of Loma Vista Medical (acquired by CR Bard), a lean start-up that created highly innovative flexible composite medical balloons. Alex has over twenty years experience leading medical device teams. He is a Stanford mechanical engineer and earned an MBA from Harvard.

Karen Drexler, Advisor

Karen is a Managing Director of ExxClaim Capital. She co-founded multiple diagnostics companies, serves as Executive Chairman of CellScape and is a member of the board of directors of diaDexus. Karen provides CEO mentoring and supports women entrepreneurs through her work with Astia and Springboard Enterprises.